Lakewood Capital Management, LP Ascendis Pharma A/S Transaction History

Lakewood Capital Management, LP

$1.16 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$127.1 - $169.66 $2.3 Million - $3.07 Million	-18,100 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $6.69 Million - $10.5 Million	-59,350 Reduced 76.63%	18,100 $2.89 Million
Q2 2021 Aug 16, 2021	SELL	$121.62 - $145.29 $486,480 - $581,160	-4,000 Reduced 4.91%	77,450 $10.2 Million
Q1 2021 May 17, 2021	SELL	$124.92 - $173.33 $1.75 Million - $2.43 Million	-14,000 Reduced 14.67%	81,450 $10.5 Million
Q4 2020 Feb 16, 2021	SELL	$151.2 - $182.76 $3.02 Million - $3.66 Million	-20,000 Reduced 17.32%	95,450 $15.9 Million
Q3 2020 Nov 16, 2020	SELL	$134.29 - $154.32 $2.01 Million - $2.31 Million	-15,000 Reduced 11.5%	115,450 $17.8 Million
Q2 2020 Aug 14, 2020	SELL	$110.87 - $156.01 $2.22 Million - $3.12 Million	-20,000 Reduced 13.29%	130,450 $19.3 Million
Q1 2020 May 15, 2020	SELL	$97.01 - $145.11 $11.6 Million - $17.4 Million	-120,000 Reduced 44.37%	150,450 $16.9 Million
Q4 2019 Feb 14, 2020	SELL	$91.45 - $139.12 $3.66 Million - $5.56 Million	-40,000 Reduced 12.88%	270,450 $37.6 Million
Q3 2019 Nov 14, 2019	SELL	$95.8 - $118.9 $43.9 Million - $54.4 Million	-457,743 Reduced 59.59%	310,450 $29.9 Million
Q2 2019 Aug 14, 2019	SELL	$107.11 - $132.09 $25.7 Million - $31.7 Million	-240,000 Reduced 23.8%	768,193 $88.5 Million
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $12.3 Million - $25.8 Million	198,600 Added 24.53%	1,008,193 $119 Million
Q4 2018 Feb 14, 2019	BUY	$55.16 - $69.67 $1.27 Million - $1.61 Million	23,100 Added 2.94%	809,593 $50.7 Million
Q3 2018 Nov 14, 2018	BUY	$63.77 - $76.28 $21.4 Million - $25.6 Million	335,967 Added 74.57%	786,493 $55.7 Million
Q2 2018 Aug 14, 2018	BUY	$58.55 - $73.92 $26.4 Million - $33.3 Million	450,526 New	450,526 $30 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

Ra Capital Management, L.P. Boston, MA

9.71M
Shares

$1.32 Billion
20.22% of portfolio
Westfield Capital Management CO LP Boston, MA

5.13M
Shares

$700 Million
3.62% of portfolio
Avoro Capital Advisors LLC New York, NY

4.99M
Shares

$680 Million
11.21% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.41M
Shares

$602 Million
1.03% of portfolio
Janus Henderson Group PLC London, X0

4.19M
Shares

$571 Million
0.33% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lakewood Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lakewood Capital Management, LP with notifications on news.

Account